# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-057888
Filing Date
2021-11-22
Accepted
2021-11-22 16:33:04
Documents
77
Period of Report
2021-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | arwr-10k_20210930.htm iXBRL | 10-K | 3274219
2 | EX-21.1 | arwr-ex211_11.htm | EX-21.1 | 3277
3 | EX-23.1 | arwr-ex231_12.htm | EX-23.1 | 3745
4 | EX-31.1 | arwr-ex311_6.htm | EX-31.1 | 10353
5 | EX-31.2 | arwr-ex312_15.htm | EX-31.2 | 10360
6 | EX-32.1 | arwr-ex321_10.htm | EX-32.1 | 5656
7 | EX-32.2 | arwr-ex322_14.htm | EX-32.2 | 5659
8 | GRAPHIC | gfmvgbft1fv3000002.jpg | GRAPHIC | 395801
9 | GRAPHIC | gfmvgbft1fv3000003.jpg | GRAPHIC | 32978
10 | GRAPHIC | gfmvgbft1fv3000005.jpg | GRAPHIC | 59246
11 | GRAPHIC | gfmvgbft1fv3000001.jpg | GRAPHIC | 128464
12 | GRAPHIC | gfmvgbft1fv3000004.jpg | GRAPHIC | 106078
| Complete submission text file | 0001564590-21-057888.txt |  | 11798353

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
13 | XBRL TAXONOMY EXTENSION SCHEMA | arwr-20210930.xsd | EX-101.SCH | 58437
14 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | arwr-20210930_cal.xml | EX-101.CAL | 63376
15 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | arwr-20210930_def.xml | EX-101.DEF | 199464
16 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | arwr-20210930_lab.xml | EX-101.LAB | 494230
17 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | arwr-20210930_pre.xml | EX-101.PRE | 386019
18 | EXTRACTED XBRL INSTANCE DOCUMENT | arwr-10k_20210930_htm.xml | XML | 1700692

Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-38042 | Film No.: 211432994
SIC: 2834 Pharmaceutical Preparations